Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

News Releases 2019

The information set forth in each press release posted on this page was factually accurate on the date it was issued. While these press releases remain on the Company's website, the Company assumes no duty to update the information to reflect subsequent developments. Consequently, readers of the press releases should not rely upon the information as current or accurate after their issuance dates.

Keyword Search
 
Search by Year
DateTitle 
02/13/19Charles River Laboratories Announces Fourth-Quarter and Full-Year 2018 Results and Provides 2019 GuidancePrinter Friendly Version
02/13/19Charles River Laboratories Signs Binding Offer to Acquire CitoxlabPrinter Friendly Version
01/30/19Charles River Laboratories and Toxys Enter Agreement to Offer ToxTracker® in North AmericaPrinter Friendly Version
01/17/19Charles River Laboratories Schedules Fourth-Quarter 2018 Earnings and 2019 Guidance Release and Conference CallPrinter Friendly Version
01/16/19Charles River Laboratories Selected for 2019 Bloomberg Gender-Equality IndexPrinter Friendly Version
01/11/19Charles River Laboratories and Atomwise Form a Strategic Alliance to Provide Integrated, Artificial Intelligence-Driven Drug DiscoveryPrinter Friendly Version
01/07/19Charles River Laboratories to Present at J.P. Morgan Healthcare ConferencePrinter Friendly Version

Stock Quote

CRL (common)
Price
$142.39
Change (%)
+ 0.72 (0.51%)
Volume
311,655
Exchange
NYSE
Data as of 02/21/19 4:02 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)